To characterize the molecular heterogeneity among the four genomic subtypes of cutaneous melanomas, the co-occurrence of CCND1 amplification with major driver mutations (BRAF V600, NRAS, NF1, and KIT) was analyzed in the three cohorts. The gene discussed is CCND1; the disease is cutaneous melanoma.